Bloom Energy Shares Surge on 26 Billion FuelCell Deal with European AI Cloud Provider Nebius Kevin Warsh Faces Tense Federal Reserve Debate Over Interest Rate Cuts Amid Inflation Surge Beyond Meat Reports First Quarter Financial Results Market Awaits Sector Cues Fed Minutes Reveal Officials Anticipate Rate Hikes If Iran War Keeps Inflation Elevated Investors Warn of BoomandBust Cycle in Memory Stocks Amid AI Frenzy Microsofts New Responsible Tech Lead Navigates Tension Between AI Speed and Trustworthy Development WRAP Q1 2026 Earnings Loss Per Share of 009 as Stock Edges Higher FOR Q1 2026 Earnings EPS Misses Estimates by a Narrow Margin Stock Gains 36 SLSN Q1 2026 Earnings Narrowed Loss Amidst Operational Uncertainty NAKA Q4 2025 Earnings Significant EPS Miss Sends Shares Lower Sequans Communications Q1 2026 Earnings Significant Earnings Miss Amid Strategic Challenges SID Q1 2026 Earnings Steelmaker Reports WiderthanExpected Loss Shares Rise Despite Miss China Pharma Holdings CPHI Hovers Near Support as MicroCap Stock Holds Slim Gains iPower Inc IPW Surges Above Support Eyes Resistance at 446 Donnelley Financial Solutions DFIN Holds Near Resistance as Volume Eases Janus Henderson Group JHG Holds Steady Near 52 Key Levels and Volume Dynamics Globus Maritime GLBS Edges Higher Testing Key Resistance Level Bushs Built a BillionDollar Fortune from Americas Favorite Baked Beans Monarch Casino Resort Inc MCRI Q1 2026 Earnings EPS Surges 349 Above Expectations LanzaTech Global Warrants LNZAW Slide Further as Price Holds at Penny Levels Micron Technology MU Edges Lower Amid Sector Rotation Key Support in Focus SCYNEXIS SCYX Falls 688 Key Support and Resistance Levels Under Scrutiny New Mountain Finance Corporation 8250 Notes due 2028 NMFCZ Holds Steady at 2527 Amidst Stable Trading BingEx FLX Rallies from Support Testing Key Resistance at 237 American Battery Technology Company ABAT Surges 6 as Support Holds Key Levels to Watch Aethlon Medical AEMD Rallies 476 Can It Hold Above Support Polaryx Therapeutics PLYX Slips 863 as Biotech Volatility Resurfaces Key Support Levels in Focus